Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Cartesian Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 97 | 2 | 86 | −9 |
| Shares | 63.7M | 3.79M | 55.6M | −4.25M (−7.1%) |
| Value | $104.9M | $6.22M | $62.8M | −$35.9M (−36.4%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Delphi Financial Group, Inc. | 660,852 | $746.8K | 0.38% |
| Mirabella Financial Services LLP | 34,875 | $39.4K | 0.00% |
| Invesco Ltd. | 20,780 | $23.5K | 0.00% |
| Balyasny Asset Management LLC | 20,717 | $23.4K | 0.00% |
| Belpointe Asset Management LLC | 8,731 | $9.87K | 0.00% |
| Advisory Services Network, LLC | 6,000 | $6.78K | 0.00% |
| Farther Finance Advisors, LLC | 539 | $609 | 0.00% |
| Sofos Investments, Inc. | 1 | – | – |
Sold out (17)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Deutsche Bank AG | 557,276 | $914.0K |
| Fred Alger Management, LLC | 220,031 | $361.0K |
| Cubist Systematic Strategies, LLC | 76,834 | $126.0K |
| Bailard, Inc. | 52,200 | $86.0K |
| Bayesian Capital Management, LP | 44,274 | $73.0K |
| Group One Trading, L.P. | 43,905 | $72.0K |
| Jane Street Group, LLC | 38,228 | $63.0K |
| LMR Partners LLP | 32,834 | $54.0K |
| Principal Financial Group Inc | 26,843 | $44.0K |
| Virtu Financial LLC | 22,925 | $38.0K |
| Occudo Quantitative Strategies LP | 20,453 | $34.0K |
| Bridgeway Capital Management, LLC | 19,200 | $31.0K |
| Schonfeld Strategic Advisors LLC | 15,300 | $25.0K |
| US Bancorp | 15,000 | $24.0K |
| UBS Group AG | 11,102 | $18.0K |
| Spire Wealth Management | 3,000 | $5.00K |
| Point72 Hong Kong Ltd | 2,219 | $4.00K |
Not filed for Q4 2022 yet (2)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| NanoDimension, Inc. | 3,787,515 | $6.21M |
| American Portfolios Advisors | 7,250 | $11.9K |